Literature DB >> 35001091

Infographic: "Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)".

Shaun Sebastian Sim1,2, Chinmayi Himanshuroy Vyas1, Rubamalar Gunatheesan1, Pooi Wah Lott1,3, Christopher Ziyu Sun1, Kelvin Yi Chong Teo1,2, Chui Ming Gemmy Cheung4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35001091      PMCID： PMC9151907          DOI： 10.1038/s41433-021-01874-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   4.456


× No keyword cloud information.
  2 in total

1.  Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study.

Authors:  Tien Yin Wong; Yuichiro Ogura; Won Ki Lee; Tomohiro Iida; Shih-Jen Chen; Paul Mitchell; Chui Ming Gemmy Cheung; Zhongqi Zhang; Sérgio Leal; Tatsuro Ishibashi
Journal:  Am J Ophthalmol       Date:  2019-03-06       Impact factor: 5.258

2.  Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial.

Authors:  Won Ki Lee; Tomohiro Iida; Yuichiro Ogura; Shih-Jen Chen; Tien Yin Wong; Paul Mitchell; Gemmy Chui Ming Cheung; Zhongqi Zhang; Sérgio Leal; Tatsuro Ishibashi
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.